ANEB
Anebulo Pharmaceuticals (ANEB)
$88
About Anebulo Pharmaceuticals (ANEB)
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.
Details
Daily high
$1.95
Daily low
$1.87
Price at open
$1.87
52 Week High
$3.30
52 Week Low
$1.62
Market cap
48.8M
Dividend yield
0.00%
Volume
1,040
Avg. volume
16,815
P/E ratio
-5.91
Anebulo Pharmaceuticals News
Details
Daily high
$1.95
Daily low
$1.87
Price at open
$1.87
52 Week High
$3.30
52 Week Low
$1.62
Market cap
48.8M
Dividend yield
0.00%
Volume
1,040
Avg. volume
16,815
P/E ratio
-5.91